Quest Diagnostics Total Non-Operating Income/Expense 2010-2024 | DGX

Quest Diagnostics annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
  • Quest Diagnostics total non-operating income/expense for the quarter ending September 30, 2024 was $-0.034B, a 20.93% decline year-over-year.
  • Quest Diagnostics total non-operating income/expense for the twelve months ending September 30, 2024 was $-0.139B, a 8.59% increase year-over-year.
  • Quest Diagnostics annual total non-operating income/expense for 2023 was $-0.132B, a 31.61% decline from 2022.
  • Quest Diagnostics annual total non-operating income/expense for 2022 was $-0.193B, a 188.53% decline from 2021.
  • Quest Diagnostics annual total non-operating income/expense for 2021 was $0.218B, a 350.57% decline from 2020.
Quest Diagnostics Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $-132
2022 $-193
2021 $218
2020 $-87
2019 $-155
2018 $-175
2017 $-135
2016 $-191
2015 $-296
2014 $-160
2013 $-151
2012 $-133
2011 $-138
2010 $-109
2009 $-131
Quest Diagnostics Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-09-30 $-34
2024-06-30 $-41
2024-03-31 $-34
2023-12-31 $-30
2023-09-30 $-43
2023-06-30 $-31
2023-03-31 $-28
2022-12-31 $-26
2022-09-30 $-41
2022-06-30 $-65
2022-03-31 $-61
2021-12-31 $-34
2021-09-30 $2
2021-06-30 $284
2021-03-31 $-34
2020-12-31 $-37
2020-09-30 $35
2020-06-30 $-28
2020-03-31 $-57
2019-12-31 $-35
2019-09-30 $-43
2019-06-30 $-42
2019-03-31 $-35
2018-12-31 $-53
2018-09-30 $-38
2018-06-30 $-41
2018-03-31 $-43
2017-12-31 $-35
2017-09-30 $-40
2017-06-30 $-27
2017-03-31 $-33
2016-12-31 $-34
2016-09-30 $-33
2016-06-30 $-39
2016-03-31 $-85
2015-12-31 $-33
2015-09-30 $-39
2015-06-30 $-101
2015-03-31 $-123
2014-12-31 $-53
2014-09-30 $-42
2014-06-30 $-33
2014-03-31 $-32
2013-12-31 $-56
2013-09-30 $-32
2013-06-30 $-33
2013-03-31 $-30
2012-12-31 $-34
2012-09-30 $-34
2012-06-30 $-36
2012-03-31 $-30
2011-12-31 $-32
2011-09-30 $-39
2011-06-30 $-39
2011-03-31 $-28
2010-12-31 $-25
2010-09-30 $-26
2010-06-30 $-36
2010-03-31 $-22
2009-12-31 $-38
2009-09-30 $-22
2009-06-30 $-38
2009-03-31 $-34
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.912B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00